The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Solovey N.V.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Shcherba V.V.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Bylina A.O.

City Clinical Infectious Disease Hospital, Minsk, Belarus

Komarova Yu.A.

City Clinical Infectious Disease Hospital, Minsk, Belarus

It’s crawling, it’s crawling!

Authors:

Solovey N.V., Shcherba V.V., Bylina A.O., Komarova Yu.A.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(3): 48‑57

Read: 270 times

To cite this article:

Solovey NV, Shcherba VV, Bylina AO, Komarova YuA. It’s crawling, it’s crawling! Non Nocere. New Therapeutic Journal. 2025;(3):48‑57. (In Russ.)

References:

  1. AlMukdad S, Harfouche M, Farooqui US, Aldos L, Abu-Raddad LJ. Epidemiology of herpes simplex virus type 1 and genital herpes in Australia and New Zealand: systematic review, meta-analyses and meta-regressions. Epidemiol Infect. 2023 Feb 8;151: e33.  https://doi.org/10.1017/S0950268823000183
  2. Yousuf W, Ibrahim H, Harfouche M, Abu Hijleh F, Abu-Raddad L. Herpes simplex virus type 1 in Europe: systematic review, meta- analyses and meta-regressions. BMJ Glob Health. 2020 Jul;5(7):e002388. https://doi.org/10.1136/bmjgh-2020-002388
  3. Ayoub HH, Chemaitelly H, Abu-Raddad LJ. Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions. BMC Med. 2019 Mar 11;17(1):57.  https://doi.org/10.1186/s12916-019-1285-x
  4. James C, Harfouche M, Welton NJ, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020 May 1;98(5):315-329.  https://doi.org/10.2471/BLT.19.237149
  5. Alareeki A, Osman AMM, Khandakji MN, Looker KJ, Harfouche M, Abu-Raddad LJ. Epidemiology of herpes simplex virus type 2 in Europe: systematic review, meta-analyses, and meta-regressions. Lancet Reg Health Eur. 2022 Dec 12;25:100558. https://doi.org/10.1016/j.lanepe.2022.100558
  6. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. 2007 Nov;57(5):737-763; quiz 764-6.  https://doi.org/10.1016/j.jaad.2007.06.027
  7. Glick M. Clinical aspects of recurrent oral herpes simplex virus infection. Compend Contin Educ Dent. 2002 Jul;23(7 Suppl 2):4-8. 
  8. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet. 2001 May 12;357(9267): 1513-1518. https://doi.org/10.1016/S0140-6736(00)04638-9
  9. Rooney JF, Straus SE, Mannix ML, et al. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med. 1993 Feb 15; 118(4):268-272.  https://doi.org/10.7326/0003-4819-118-4-199302150-00004
  10. Nadelman CM, Newcomer VD. Herpes simplex virus infections. New treatment approaches make early diagnosis even more important. Postgrad Med. 2000 Mar;107(3):189-200.  https://doi.org/10.3810/pgm.2000.03.948
  11. Wilms L, Weßollek K, Peeters TB, Yazdi AS. Infections with Herpes simplex and Varicella zoster virus. J Dtsch Dermatol Ges. 2022 Oct;20(10):1327-1351. https://doi.org/10.1111/ddg.14917
  12. Siegel MA. Diagnosis and management of recurrent herpes simplex infections. J Am Dent Assoc. 2002 Sep;133(9):1245-1249. https://doi.org/10.14219/jada.archive.2002.0366
  13. Beauman JG. Genital herpes: a review. Am Fam Physician. 2005 Oct 15;72(8):1527-1534.
  14. Ahmed J, Rawre J, Dhawan N, Dudani P, Khanna N, Dhawan B. Genital ulcer disease: A review. J Family Med Prim Care. 2022 Aug;11(8):4255-4262. https://doi.org/10.4103/jfmpc.jfmpc_2111_21
  15. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983 Jun;98(6):958-972.  https://doi.org/10.7326/0003-4819-98-6-958
  16. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994 Dec 1;121(11): 847-854.  https://doi.org/10.7326/0003-4819-121-11-199412010-00004
  17. Mertz GJ, Rosenthal SL, Stanberry LR. Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? Sex Transm Dis. 2003 Oct;30(10):801-802.  https://doi.org/10.1097/01.OLQ.0000093080.55201.D1
  18. Sacks SL, Griffiths PD, Corey L, et al. HSV shedding. Antiviral Res. 2004 Aug;63 Suppl 1:S19-26.  https://doi.org/10.1016/j.antiviral.2004.06.004
  19. Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med. 1999 Jul 6;131(1):14-20.  https://doi.org/10.7326/0003-4819-131-1-199907060-00004
  20. Simmons A. Clinical manifestations and treatment considerations of herpes simplex virus infection. J Infect Dis. 2002 Oct 15;186 Suppl 1:S71-77.  https://doi.org/10.1086/342967
  21. Cooper BL. Eczema Herpeticum. J Emerg Med. 2017 Sep;53(3):412-413.  https://doi.org/10.1016/j.jemermed.2016.12.004
  22. Marcus B, Lipozencić J, Matz H, Orion E, Wolf R. Herpes simplex: autoinoculation versus dissemination. Acta Dermatovenerol Croat. 2005;13(4):237-241. 
  23. Mirfazaelian H, Daneshbod Y. Herpes gladiatorum. Emerg Med J. 2013 Nov;30(11): 892.  https://doi.org/10.1136/emermed-2013-202419
  24. Avitzur Y, Amir J. Herpetic whitlow infection in a general pediatrician – an occupational hazard. Infection. 2002 Aug;30(4):234-236.  https://doi.org/10.1007/s15010-002-2155-5
  25. Feder HM Jr, Long SS. Herpetic whitlow. Epidemiology, clinical characteristics, diagnosis, and treatment. Am J Dis Child. 1983 Sep;137(9):861-863.  https://doi.org/10.1001/archpedi.1983.02140350035009
  26. Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Res. 2004 Feb;61(2):73-81.  https://doi.org/10.1016/j.antiviral.2003.09.006
  27. Fillet AM. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients. Drugs Aging. 2002;19(5):343-354.  https://doi.org/10.2165/00002512-200219050-00003
  28. Esmann J. The many challenges of facial herpes simplex virus infection. J Antimicrob Chemother. 2001 Feb;47 Suppl T1:17-27.  https://doi.org/10.1093/jac/47.suppl_1.17
  29. Rosenberg J, Galen BT. Recurrent Meningitis. Curr Pain Headache Rep. 2017;21(7):33.  https://doi.org/10.1007/s11916-017-0635-7
  30. James SH, Kimberlin DW, Whitley RJ. Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res. 2009 Sep;83(3):207-213.  https://doi.org/10.1016/j.antiviral.2009.04.010
  31. Marcocci ME, Napoletani G, Protto V, et al. Herpes Simplex Virus-1 in the Brain: The Dark Side of a Sneaky Infection. Trends Microbiol. 2020 Oct;28(10):808-820.  https://doi.org/10.1016/j.tim.2020.03.003
  32. Riera-Mestre A, Gubieras L, Martínez-Yelamos S, Cabellos C, Fernández-Viladrich P. Adult herpes simplex encephalitis: fifteen years’ experience. Enferm Infecc Microbiol Clin. 2009 Mar;27(3):143-147.  https://doi.org/10.1016/j.eimc.2008.05.006
  33. Kornienko VN, Pronin IN. Diagnostic Neuroradiology. AJNR Am J Neuroradiol. 2009;30(9): E136. https://doi.org/10.3174/ajnr.A1709
  34. Lynch DP. Oral viral infections. Clin Dermatol. 2000 Sep-Oct;18(5):619-628.  https://doi.org/10.1016/s0738-081x(00)00138-3
  35. Strick LB, Wald A. Diagnostics for herpes simplex virus: is PCR the new gold standard? Mol Diagn Ther. 2006;10(1):17-28.  https://doi.org/10.1007/BF03256439
  36. Spruance S, Aoki FY, Tyring S, Stanberry L, Whitley R, Hamed K. Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract. 2007 Jan;56(1): 30-36. 
  37. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008 Jun 9;168(11):1137-1144. https://doi.org/10.1001/archinte.168.11.1137
  38. Pouplin T, Pouplin JN, Van Toi P, et al. Valacyclovir for herpes simplex encephalitis. Antimicrob Agents Chemother. 2011 Jul;55(7):3624-3626. https://doi.org/10.1128/AAC.01023-10
  39. Cunha BA, Baron J. The pharmacokinetic basis of oral valacyclovir treatment of herpes simplex virus (HSV) or varicella zoster virus (VZV) meningitis, meningoencephalitis or encephalitis in adults. J Chemother. 2017 Apr;29(2):122-125.  https://doi.org/10.1179/1973947815Y.0000000065

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.